ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $454,237 | +78.3% | 16,905 | +68.6% | 0.00% | +200.0% |
Q2 2023 | $254,736 | 0.0% | 10,029 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $254,736 | -59.9% | 10,029 | -36.0% | 0.00% | -75.0% |
Q4 2022 | $635,291 | +24.6% | 15,663 | +1.3% | 0.00% | +33.3% |
Q3 2022 | $510,000 | +44.9% | 15,462 | +54.5% | 0.00% | +50.0% |
Q2 2022 | $352,000 | -23.3% | 10,007 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $459,000 | -30.9% | 10,007 | -0.1% | 0.00% | -33.3% |
Q4 2021 | $664,000 | +6.4% | 10,018 | +0.1% | 0.00% | 0.0% |
Q3 2021 | $624,000 | -24.9% | 10,007 | -0.3% | 0.00% | -25.0% |
Q2 2021 | $831,000 | +25.3% | 10,038 | +0.3% | 0.00% | 0.0% |
Q1 2021 | $663,000 | -13.7% | 10,007 | -0.1% | 0.00% | 0.0% |
Q4 2020 | $768,000 | +78.6% | 10,018 | +0.2% | 0.00% | +33.3% |
Q3 2020 | $430,000 | -0.5% | 10,000 | -0.3% | 0.00% | 0.0% |
Q2 2020 | $432,000 | -36.3% | 10,028 | -6.3% | 0.00% | 0.0% |
Q1 2020 | $678,000 | 0.0% | 10,697 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $678,000 | +126.8% | 10,697 | +0.5% | 0.00% | +200.0% |
Q3 2019 | $299,000 | +9.9% | 10,643 | +3.7% | 0.00% | 0.0% |
Q2 2019 | $272,000 | +48.6% | 10,267 | +2.7% | 0.00% | 0.0% |
Q1 2019 | $183,000 | +47.6% | 10,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $124,000 | -35.1% | 10,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $191,000 | +40.4% | 10,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $136,000 | +277.8% | 10,000 | 0.0% | 0.00% | – |
Q1 2018 | $36,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
Q4 2017 | $36,000 | +71.4% | 10,000 | +100.0% | 0.00% | – |
Q3 2017 | $21,000 | +133.3% | 5,000 | 0.0% | 0.00% | – |
Q2 2017 | $9,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
Q1 2017 | $9,000 | +28.6% | 5,000 | 0.0% | 0.00% | – |
Q4 2016 | $7,000 | -90.4% | 5,000 | -50.0% | 0.00% | – |
Q3 2016 | $73,000 | +37.7% | 10,000 | 0.0% | 0.00% | – |
Q2 2016 | $53,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |